These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 15964338

  • 1. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.
    Attallah N, Goggins M, Nori U, Abouljoud M, Zasuwa G, Venkat KK, Parasuraman R.
    Transplant Proc; 2005 Jun; 37(5):2060-2. PubMed ID: 15964338
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 2001 Apr 27; 71(8):1091-7. PubMed ID: 11374408
    [Abstract] [Full Text] [Related]

  • 3. Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression.
    Lou HX, Vathsala A.
    Transplant Proc; 2004 Sep 27; 36(7):2090-1. PubMed ID: 15518756
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y.
    Transplantation; 2012 Feb 27; 93(4):437-43. PubMed ID: 22228415
    [Abstract] [Full Text] [Related]

  • 5. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT, Pham PC.
    Nephrol Dial Transplant; 2012 Jul 27; 27(7):2965-71. PubMed ID: 22207327
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T, Johnson C, Ahsan N, Alfrey EJ, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Leonhardt M, Fitzsimmons WE.
    Transplantation; 2003 Jun 27; 75(12):2048-53. PubMed ID: 12829910
    [Abstract] [Full Text] [Related]

  • 7. Effect of mycophenolate mofetil on kidney graft function and body weight in patients with chronic allograft nephropathy.
    Grebe SO, Mueller TF, Troeltsch M, Ebel H, Lange H.
    Transplant Proc; 2004 Dec 27; 36(10):2974-8. PubMed ID: 15686673
    [Abstract] [Full Text] [Related]

  • 8. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

  • 9. Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.
    Zhu B, Liu Z, Wu C, Wang P, Wang X, Xu H.
    Transplant Proc; 2008 Sep 15; 40(7):2258-61. PubMed ID: 18790207
    [Abstract] [Full Text] [Related]

  • 10. New immunosuppressive treatment in kidney transplantation.
    Di Landro D, Sarzo G, Marchini F.
    Clin Nephrol; 2000 Apr 15; 53(4):suppl 23-32. PubMed ID: 10809431
    [Abstract] [Full Text] [Related]

  • 11. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
    Ahsan N, Johnson C, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.
    Transplantation; 2001 Jul 27; 72(2):245-50. PubMed ID: 11477347
    [Abstract] [Full Text] [Related]

  • 12. 36-month follow-up of 75 renal allograft recipients treated with steroids, tacrolimus, and azathioprine or mycophenolate mofetil.
    Mucha K, Foroncewicz B, Paczek L, Pazik J, Lewandowska D, Krawczyk A, Pliszczynski J, Gradowska L, Durlik M, Walaszewski J, Nazarewski S, Szmidt J.
    Transplant Proc; 2003 Sep 27; 35(6):2176-8. PubMed ID: 14529880
    [Abstract] [Full Text] [Related]

  • 13. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
    Triemer HL, Pearson TC, Odom KL, Larsen CP.
    Clin Transplant; 2000 Aug 27; 14(4 Pt 2):413-20. PubMed ID: 10946781
    [Abstract] [Full Text] [Related]

  • 14. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S, Daswani A, Takemoto SK.
    Transplantation; 2003 Jul 15; 76(1):10-5. PubMed ID: 12865780
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.
    Meier-Kriesche HU, Steffen BJ, Hochberg AM, Gordon RD, Liebman MN, Morris JA, Kaplan B.
    Transplantation; 2003 Apr 27; 75(8):1341-6. PubMed ID: 12717227
    [Abstract] [Full Text] [Related]

  • 16. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Mathew TH.
    Transplantation; 1998 Jun 15; 65(11):1450-4. PubMed ID: 9645801
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial.
    Clayton PA, McDonald SP, Chapman JR, Chadban SJ.
    Transplantation; 2012 Jul 27; 94(2):152-8. PubMed ID: 22728292
    [Abstract] [Full Text] [Related]

  • 18. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
    Flechner SM, Zhou L, Derweesh I, Mastroianni B, Savas K, Goldfarb D, Modlin CS, Krishnamurthi V, Novick A.
    Transplantation; 2003 Dec 27; 76(12):1729-34. PubMed ID: 14688524
    [Abstract] [Full Text] [Related]

  • 19. Changing treatment protocol from azathioprine to mycophenolate mofetil: decrease in renal dysfunction, increase in infections.
    Pourfarziani V, Panahi Y, Assari S, Moghani-Lankarani M, Saadat SH.
    Transplant Proc; 2007 May 27; 39(4):1237-40. PubMed ID: 17524943
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.